Ma Yaokai, Wu Qing, Li Xin, Gu Xiaoqiang, Xu Jiahua, Yang Jinzu
Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.
Ann Transl Med. 2016 Dec;4(23):458. doi: 10.21037/atm.2016.11.57.
Pancreatic cancer is recognized as the king of carcinoma, and the gap between basic research and clinical practice is difficult to improve the treatment effect. Translational medicine builds an important bridge between pancreatic cancer basic research and clinical practice from the pathogenesis, early diagnosis of pancreatic carcinoma, drug screening, treatment strategies and metastasis prediction. This article will carry on the concrete elaboration to the above several aspects.
胰腺癌被公认为癌中之王，基础研究与临床实践之间的差距难以提高治疗效果。转化医学从胰腺癌的发病机制、早期诊断、药物筛选、治疗策略及转移预测等方面，在胰腺癌基础研究与临床实践之间搭建了一座重要的桥梁。本文将对上述几个方面进行具体阐述。
